The Mitochondrial Complex I Activity Is Reduced in Cells with Impaired Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Valdivieso, Angel G ^a   Clauzure, Mariángeles ^a   Marín, María C ^a,b   Taminelli, Guillermo L ^a   Massip Copiz, María M ^a   Sánchez, Francisco ^a   Schulman, Gustavo ^a   Teiber, María L ^a   Santa Coloma, Tomás A ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

^b Laboratorios Richmond   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

5 [(4 CARBOXYPHENYL)METHYLENE] 2 THIOXO 3 [(3 TRIFLUOROMETHYL)PHENYL 4 THIAOLIDINONE]; GLIBENCLAMIDE; N (2 NAPHTHALENYL) [(3,5 DIBROMO 2,4 DIHYDROXYPHENYL)METHYLENE]GLYCINE HYDRAZIDE; PROTEIN INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SHORT HAIRPIN RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN; CELLULAR DISTRIBUTION; CFTR GENE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MCX 1 GENE; PHARMACOLOGICAL BLOCKING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; WILD TYPE;

ANIMALS; CATTLE; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTRON TRANSPORT COMPLEX I; GENE KNOCKDOWN TECHNIQUES; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NADH DEHYDROGENASE; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84869849687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048059     Document Type: Article

References (74)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
2. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, et al. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059-1065.
3. Rich DP, Anderson MP, Gregory RJ, Cheng SH, Paul S, et al. (1990) Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 347: 358-363.
4. Welsh MJ, Anderson MP, Rich DP, Berger HA, Denning GM, et al. (1992) Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation. Neuron 8: 821-829.
5. Consortium TCFGA, (1994) Population variation of common cystic fibrosis mutations. Hum Mutat 4: 167-177.
6. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834.
7. Grove DE, Rosser MF, Watkins RL, Cyr DM, (2011) Analysis of CFTR folding and degradation in transiently transfected cells. Methods Mol Biol 741: 219-232.
8. Averna M, Stifanese R, Grosso R, Pedrazzi M, De Tullio R, et al. (2011) Calpain digestion and HSP90-based chaperone protection modulate the level of plasma membrane F508del-CFTR. Biochim Biophys Acta 1813: 50-59.
9. Averna M, Stifanese R, Grosso R, Pedrazzi M, De Tullio R, et al. (2010) Role of calpain in the regulation of CFTR (cystic fibrosis transmembrane conductance regulator) turnover. Biochem J 430: 255-263.
10. Shapiro BL, Feigal RJ, Lam LF, (1979) Mitrochondrial NADH dehydrogenase in cystic fibrosis. Proc Natl Acad Sci U S A 76: 2979-2983.
11. Shapiro BL, Lam LF, Feigal RJ, (1982) Mitochondrial NADH dehydrogenase in cystic fibrosis: enzyme kinetics in cultured fibroblasts. Am J Hum Genet 34: 846-852.
12. Feigal RJ, Tomczyk MS, Shapiro BL, (1982) The calcium abnormality in cystic fibrosis mitochondria: relative role of respiration and ATP hydrolysis. Life Sci 30: 93-98.
13. Antigny F, Girardin N, Raveau D, Frieden M, Becq F, et al. (2009) Dysfunction of mitochondria Ca2+ uptake in cystic fibrosis airway epithelial cells. Mitochondrion 9: 232-241.
14. Taminelli GL, Sotomayor V, Valdivieso AG, Teiber ML, Marin MC, et al. (2008) CISD1 codifies a mitochondrial protein upregulated by the CFTR channel. Biochem Biophys Res Commun 365: 856-862.
15. Valdivieso AG, Marcucci F, Taminelli G, Guerrico AG, Alvarez S, et al. (2007) The expression of the mitochondrial gene MT-ND4 is downregulated in cystic fibrosis. Biochem Biophys Res Commun 356: 805-809.
16. Velsor LW, Kariya C, Kachadourian R, Day BJ, (2006) Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am J Respir Cell Mol Biol 35: 579-586.
17. Gonzalez-Guerrico AM, Cafferata EG, Radrizzani M, Marcucci F, Gruenert D, et al. (2002) Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis. J Biol Chem 277: 17239-17247.
18. Colca JR, McDonald WG, Waldon DJ, Leone JW, Lull JM, et al. (2004) Identification of a novel mitochondrial protein ("mitoNEET" cross-linked specifically by a thiazolidinedione photoprobe. Am J Physiol Endocrinol Metab 286: E252-260.
19. Bieganski RM, Yarmush ML, (2011) Novel ligands that target the mitochondrial membrane protein mitoNEET. J Mol Graph Model 29: 965-973.
20. Baxter EL, Jennings PA, Onuchic JN, (2011) Interdomain communication revealed in the diabetes drug target mitoNEET. Proc Natl Acad Sci U S A 108: 5266-5271.
21. Zhou T, Lin J, Feng Y, Wang J, (2010) Binding of reduced nicotinamide adenine dinucleotide phosphate destabilizes the iron-sulfur clusters of human mitoNEET. Biochemistry 49: 9604-9612.
22. Kaundal RK, Sharma SS, (2010) Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents. Drug News Perspect 23: 241-256.
23. Bak DW, Zuris JA, Paddock ML, Jennings PA, Elliott SJ, (2009) Redox characterization of the FeS protein MitoNEET and impact of thiazolidinedione drug binding. Biochemistry 48: 10193-10195.
24. Conlan AR, Paddock ML, Axelrod HL, Cohen AE, Abresch EC, et al. (2009) The novel 2Fe-2S outer mitochondrial protein mitoNEET displays conformational flexibility in its N-terminal cytoplasmic tethering domain. Acta Crystallogr Sect F Struct Biol Cryst Commun 65: 654-659.
25. Wiley SE, Rardin MJ, Dixon JE, (2009) Chapter 13 Localization and function of the 2Fe-2S outer mitochondrial membrane protein mitoNEET. Methods Enzymol 456: 233-246.
26. Zuris JA, Harir Y, Conlan AR, Shvartsman M, Michaeli D, et al. (2011) Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proc Natl Acad Sci U S A.
27. Hatefi Y, (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54: 1015-1069.
28. Smeitink JA, van den Heuvel LW, Koopman WJ, Nijtmans LG, Ugalde C, et al. (2004) Cell biological consequences of mitochondrial NADH: ubiquinone oxidoreductase deficiency. Curr Neurovasc Res 1: 29-40.
29. Bourges I, Ramus C, Mousson de Camaret B, Beugnot R, Remacle C, et al. (2004) Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin. Biochem J 383: 491-499.
30. Hofhaus G, Attardi G, (1993) Lack of assembly of mitochondrial DNA-encoded subunits of respiratory NADH dehydrogenase and loss of enzyme activity in a human cell mutant lacking the mitochondrial ND4 gene product. Embo J 12: 3043-3048.
31. Degli Esposti M, Carelli V, Ghelli A, Ratta M, Crimi M, et al. (1994) Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy. FEBS Lett 352: 375-379.
32. Lodi R, Montagna P, Cortelli P, Iotti S, Cevoli S, et al. (2000) 'econdary'4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation. Brain 123 (Pt 9): 1896-1902.
33. Majander A, Huoponen K, Savontaus ML, Nikoskelainen E, Wikstrom M, (1991) Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett 292: 289-292.
34. Shapiro BL, (1989) Evidence for a mitochondrial lesion in cystic fibrosis. Life Sci 44: 1327-1334.
35. Shapiro BL, (1988) Mitochondrial dysfunction, energy expenditure, and cystic fibrosis. Lancet 2: 289.
36. Feigal RJ, Shapiro BL, (1986) Cystic fibrosis-a lethal exocrinopathy with altered mitochondrial calcium metabolism. Ann N Y Acad Sci 488: 82-98.
37. Feigal RJ, Shapiro BL, (1979) Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis. Nature 278: 276-277.
38. Lei DC, Kunzelmann K, Koslowsky T, Yezzi MJ, Escobar LC, et al. (1996) Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells. Gene Ther 3: 427-436.
39. Zeitlin PL, Lu L, Rhim J, Cutting G, Stetten G, et al. (1991) A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 4: 313-319.
40. Egan M, Flotte T, Afione S, Solow R, Zeitlin PL, et al. (1992) Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR. Nature 358: 581-584.
41. Cafferata EG, Gonzalez-Guerrico AM, Giordano L, Pivetta OH, Santa-Coloma TA, (2000) Interleukin-1beta regulates CFTR expression in human intestinal T84 cells. Biochim Biophys Acta 1500: 241-248.
42. Gregory RJ, Cheng SH, Rich DP, Marshall J, Paul S, et al. (1990) Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 347: 382-386.
43. Strong TV, Boehm K, Collins FS, (1994) Localization of cystic fibrosis transmembrane conductance regulator mRNA in the human gastrointestinal tract by in situ hybridization. J Clin Invest 93: 347-354.
44. Lowry OH, Rosebroug NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. JBiolChem 193: 265-275.
45. Schagger H, von Jagow G, (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199: 223-231.
46. Zerbetto E, Vergani L, Dabbeni-Sala F, (1997) Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels. Electrophoresis 18: 2059-2064.
47. Lojda Z, Gossrau R, Schiebler TH (1979) in Enzyme Histochemistry, a Laboratory Manual. p. 256-266.
48. Joshi AK, Raju N, Rajini PS, (2011) Microplate-based kinetic method for assay of mitochondrial NADH- and succinate-cytochrome c reductase activities. Anal Biochem 415: 209-211.
49. Navarro A, Bandez MJ, Gomez C, Repetto MG, Boveris A, (2010) Effects of rotenone and pyridaben on complex I electron transfer and on mitochondrial nitric oxide synthase functional activity. J Bioenerg Biomembr 42: 405-412.
50. Wagner JA, McDonald TV, Nghiem PT, Lowe AW, Schulman H, et al. (1992) Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents. Proc Natl Acad Sci U S A 89: 6785-6789.
51. Tondelier D, Brouillard F, Lipecka J, Labarthe R, Bali M, et al. (1999) Aspirin and some other nonsteroidal anti-inflammatory drugs inhibit cystic fibrosis transmembrane conductance regulator protein gene expression in T-84 cells. Mediators Inflamm 8: 219-227.
52. Verkman AS, (1990) Development and biological applications of chloride-sensitive fluorescent indicators. Am J Physiol 259: C375-388.
53. Valdivieso AG, Marín MC, Clauzure M, Santa-Coloma TA, (2011) Measurement of CFTR activity using Fluorescence Spectrophotometry. Analytical Biochemistry 418(2): 231-237 doi: 101016/jab201107029.
54. Nijtmans LG, Henderson NS, Holt IJ, (2002) Blue Native electrophoresis to study mitochondrial and other protein complexes. Methods 26: 327-334.
55. Sood R, Bear C, Auerbach W, Reyes E, Jensen T, et al. (1992) Regulation of CFTR expression and function during differentiation of intestinal epithelial cells. Embo J 11: 2487-2494.
56. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, et al. (2002) Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658.
57. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, et al. (2004) Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 124: 125-137.
58. Kelly M, Trudel S, Brouillard F, Bouillaud F, Colas J, et al. (2010) Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition. J Pharmacol Exp Ther 333: 60-69.
59. Kelly-Aubert M, Trudel S, Fritsch J, Nguyen-Khoa T, Baudouin-Legros M, et al. (2011) GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models. Hum Mol Genet 20: 2745-2759.
60. MacVinish LJ, Cope G, Ropenga A, Cuthbert AW, (2007) Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR. Br J Pharmacol 150: 1055-1065.
61. Estell K, Braunstein G, Tucker T, Varga K, Collawn JF, et al. (2003) Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. Mol Cell Biol 23: 594-606.
62. Pitkanen S, Feigenbaum A, Laframboise R, Robinson BH, (1996) NADH-coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findings. J Inherit Metab Dis 19: 675-686.
63. He Y, Leung KW, Zhang YH, Duan S, Zhong XF, et al. (2008) Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants. Invest Ophthalmol Vis Sci 49: 1447-1458.
64. Chomova M, Racay P, (2010) Mitochondrial complex I in the network of known and unknown facts. Gen Physiol Biophys 29: 3-11.
65. Wijburg FA, Feller N, de Groot CJ, Wanders RJ, (1990) Menadione partially restores NADH-oxidation and ATP-synthesis in complex I deficient fibroblasts. Biochem Int 22: 303-309.
66. Yi JS, Holbrook BC, Michalek RD, Laniewski NG, Grayson JM, (2006) Electron transport complex I is required for CD8+ T cell function. J Immunol 177: 852-862.
67. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, et al. (2010) Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 12: 863-875.
68. l'Hoste S, Chargui A, Belfodil R, Corcelle E, Duranton C, et al. (2010) CFTR mediates apoptotic volume decrease and cell death by controlling glutathione efflux and ROS production in cultured mice proximal tubules. Am J Physiol Renal Physiol 298: F435-453.
69. Hayes E, Pohl K, McElvaney NG, Reeves EP, (2011) The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz) 59: 97-112.
70. de Meer K, Jeneson JA, Gulmans VA, van der Laag J, Berger R, (1995) Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax 50: 980-983.
71. Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, et al. (2009) Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 33: 99-106.
72. Fosslien E, (2001) Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 31: 25-67.
73. Arnoult D, Soares F, Tattoli I, Girardin SE, (2011) Mitochondria in innate immunity. EMBO Rep 12: 901-910 doi: 10.1038/embor.2011.157.
74. West AP, Shadel GS, Ghosh S, (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11: 389-402.